Novel Secondary Somatic Mutations in Ewing's Sarcoma and Desmoplastic Small Round Cell Tumors

• Yunyun Jiang ,

  Contributed equally to this work with: Yunyun Jiang, Vivek Subbiah

  Affiliation Department of Investigational Cancer Therapeutics (Phase I Clinical Trials Program), Division of Cancer Medicine, The University of Texas MD Anderson Cancer Center, Houston, Texas, United States of America

  ⨯
• Vivek Subbiah ,

  Contributed equally to this work with: Yunyun Jiang, Vivek Subbiah

  * E-mail: vsubbiah@mdanderson.org

  Affiliations Department of Investigational Cancer Therapeutics (Phase I Clinical Trials Program), Division of Cancer Medicine, The University of Texas MD Anderson Cancer Center, Houston, Texas, United States of America, Department of Pediatrics, The University of Texas MD Anderson Cancer Center, Houston, Texas, United States of America

  ⨯
• Filip Janku,

  Affiliation Department of Investigational Cancer Therapeutics (Phase I Clinical Trials Program), Division of Cancer Medicine, The University of Texas MD Anderson Cancer Center, Houston, Texas, United States of America

  ⨯
• Joseph A. Ludwig,

  Affiliation Department of Sarcoma Medical Oncology, The University of Texas MD Anderson Cancer Center, Houston, Texas, United States of America

  ⨯
• Aung Naing,

  Affiliation Department of Investigational Cancer Therapeutics (Phase I Clinical Trials Program), Division of Cancer Medicine, The University of Texas MD Anderson Cancer Center, Houston, Texas, United States of America

  ⨯
• Robert S. Benjamin,

  Affiliation Department of Sarcoma Medical Oncology, The University of Texas MD Anderson Cancer Center, Houston, Texas, United States of America

  ⨯
• Robert E. Brown,

  Affiliation From the Department of Pathology, UT Health-Department of Pathology and Laboratory medicine, Houston, Texas, United States of America

  ⨯
• Pete Anderson,

  Affiliations Department of Pediatrics, The University of Texas MD Anderson Cancer Center, Houston, Texas, United States of America, Pediatric Hematology/Oncology/BMT, Levine Children's Hospital/Levine Cancer Institute, Charlotte, North Carolina, United States of America

  ⨯
• Razelle Kurzrock

  Affiliations Department of Investigational Cancer Therapeutics (Phase I Clinical Trials Program), Division of Cancer Medicine, The University of Texas MD Anderson Cancer Center, Houston, Texas, United States of America, Center for Personalized Cancer Therapy and Division of Hematology & Oncology, University of California San Diego - Moores Cancer Center, La Jolla, California, United States of America

  ⨯